JP2005537282A5 - - Google Patents

Download PDF

Info

Publication number
JP2005537282A5
JP2005537282A5 JP2004523305A JP2004523305A JP2005537282A5 JP 2005537282 A5 JP2005537282 A5 JP 2005537282A5 JP 2004523305 A JP2004523305 A JP 2004523305A JP 2004523305 A JP2004523305 A JP 2004523305A JP 2005537282 A5 JP2005537282 A5 JP 2005537282A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
cephalotaxin
disease
angiogenic disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004523305A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005537282A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/022926 external-priority patent/WO2004009030A2/en
Publication of JP2005537282A publication Critical patent/JP2005537282A/ja
Publication of JP2005537282A5 publication Critical patent/JP2005537282A5/ja
Pending legal-status Critical Current

Links

JP2004523305A 2002-07-22 2003-07-22 セファロタキシンアルカロイドによる血管新生抑制、並びにその誘導体、組成物、および使用方法 Pending JP2005537282A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39765702P 2002-07-22 2002-07-22
PCT/US2003/022926 WO2004009030A2 (en) 2002-07-22 2003-07-22 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof

Publications (2)

Publication Number Publication Date
JP2005537282A JP2005537282A (ja) 2005-12-08
JP2005537282A5 true JP2005537282A5 (https=) 2006-09-07

Family

ID=30771096

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004523305A Pending JP2005537282A (ja) 2002-07-22 2003-07-22 セファロタキシンアルカロイドによる血管新生抑制、並びにその誘導体、組成物、および使用方法

Country Status (7)

Country Link
US (2) US7642252B2 (https=)
EP (1) EP1539179B1 (https=)
JP (1) JP2005537282A (https=)
AU (1) AU2003254120B2 (https=)
CA (1) CA2493544A1 (https=)
ES (1) ES2572145T3 (https=)
WO (1) WO2004009030A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060211648A1 (en) * 2000-04-12 2006-09-21 Chemgenex Pharmaceuticals, Inc. Naphthalimide compositions and uses thereof
US7135481B2 (en) * 2000-04-12 2006-11-14 Chemgenex Pharmaceuticals, Inc. Naphthalimide compositions and uses thereof
US20050170015A1 (en) * 2000-10-31 2005-08-04 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
US7901707B2 (en) * 2004-03-15 2011-03-08 Christine Allen Biodegradable biocompatible implant and method of manufacturing same
JP2008501719A (ja) * 2004-06-04 2008-01-24 ケムジェネックス・ファーマシューティカルズ・インコーポレイテッド ナフタルイミドおよびparp−1インヒビターを使用する細胞増殖性疾患の処置方法
JP2008529667A (ja) * 2005-02-10 2008-08-07 ケムジェネックス・ファーマシューティカルズ・インコーポレイテッド 医療デバイス
AU2008240044B2 (en) * 2007-04-13 2013-09-12 Teva Pharamceuticals International Gmbh Oral cephalotaxine dosage forms
US8466142B2 (en) 2008-03-03 2013-06-18 Sloan-Kettering Institute For Cancer Research Cephalotaxus esters, methods of synthesis, and uses thereof
US20120283306A1 (en) * 2011-04-27 2012-11-08 Georgia Health Sciences University Mouse model for avm
KR102066684B1 (ko) * 2018-02-19 2020-01-15 가천대학교 산학협력단 개비자나무 추출물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 자가면역질환의 예방 또는 치료용 조성물
KR102174166B1 (ko) * 2018-12-13 2020-11-04 영남대학교 산학협력단 호모해링토닌을 유효성분으로 함유하는 세포노화 관련 질환 예방 또는 치료용 조성물
KR102066683B1 (ko) * 2019-09-16 2020-01-15 가천대학교 산학협력단 개비자나무 추출물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 자가면역질환의 예방 또는 치료용 조성물
KR102209386B1 (ko) * 2020-01-09 2021-02-01 영남대학교 산학협력단 호모해링토닌을 유효성분으로 함유하는 대사질환 예방 또는 치료용 약학조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3793454A (en) * 1971-11-12 1974-02-19 Us Agriculture Harringtonine and isopharringtonine for treating l1210 or p388 leukemic tumors in mice
US4152214A (en) 1977-10-07 1979-05-01 The United States Of America As Represented By The Secretary Of Agriculture Production of homodeoxyharringtonine and other cephalotaxine esters by tissue culture
JPS5835146A (ja) 1981-08-28 1983-03-01 Isukura Sangyo Kk 2−ケト−6−メチル−5−ヘプテン酸エチルエステルの製造方法
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
HUT76095A (en) 1994-04-26 1997-06-30 Childrens Medical Center Angiostatin and method of use for inhibition of angiogenesis
CA2294247C (en) * 1997-07-01 2004-10-26 Atherogenics, Inc. Antioxidant enhancement of therapy for hyperproliferative conditions
US6025353A (en) * 1997-11-19 2000-02-15 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
WO2000014083A1 (en) * 1998-09-09 2000-03-16 Inflazyme Pharmaceuticals Ltd. SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO
US6465424B1 (en) * 1999-02-17 2002-10-15 Bristol-Myers Squibb Company Anti-angiogenic agent and method for inhibiting angiogenesis
JP2003527337A (ja) * 1999-11-12 2003-09-16 エントレメッド インコーポレイテッド 抗血管新生スケジュールに基づく治療薬の投与方法
PT1263440E (pt) 2000-03-15 2006-11-30 Chemgenex Pharmaceuticals Inc Composições de combinação do alcalóide cefalotaxina e sua utilização
ATE305312T1 (de) 2000-04-12 2005-10-15 Chemgenex Pharmaceuticals Inc Zusammensetzungen welche ein naphthalmid und ein antiproliferatives mittel enthalten
US6978497B1 (en) 2000-06-21 2005-12-27 Shigeo Takizawa Motivative exercise and lifting aid dual device
AU7940500A (en) 2000-10-17 2002-04-29 Oncopharm Corp New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents
ATE369894T1 (de) * 2000-11-22 2007-09-15 Novartis Pharma Gmbh Kombination enthaltend ein mittel zur verminderung von vegf-aktivität und ein mittel zur verminderung von egf-aktivität
CN100396286C (zh) * 2002-12-30 2008-06-25 北京大学第一医院 高三尖杉酯碱和三尖杉酯碱在制备抑制血管生成药物中的应用

Similar Documents

Publication Publication Date Title
JP2005537282A5 (https=)
CN1241569C (zh) 用于治疗鼻炎/结膜炎的非镇静抗组胺药物与影响白三烯活性物质的新药物并用
ES2337547T3 (es) Composiciones de liberacion controlada que contienen nimesulida.
CN111035639B (zh) 喹啉衍生物用于治疗软组织肉瘤的方法和用途以及用于治疗软组织肉瘤的药物组合物
US6503953B2 (en) Methods for treating atopic disorders
WO2021231792A1 (en) Pharmaceutical formulations and uses thereof
IL189587A (en) Solid dispersion, a pharmaceutical composition comprising the solid dispersion and process of preparing the solid dispersion
CA2432126A1 (en) Complex of modafinil and cyclodextrin
JP2004532863A5 (https=)
JP2005506987A5 (https=)
JP2005523263A5 (https=)
JP2009541409A5 (https=)
CN105560267A (zh) 白术多糖在制备化疗药物引起的肠黏膜炎及肠道菌群失调中的应用
JP2009517411A5 (https=)
CA2508312C (en) Treatment of inflammatory disorders with 2,3-benzodiazepines
JP2000302686A (ja) 腸内ガス、痙攣及び肛門直腸の過敏症を低減する方法
TW200946142A (en) Tablet
JP2009518415A5 (https=)
CN116617249B (zh) 铁皮石斛茎/叶多糖的应用
CA2563748A1 (en) Methods of using and compositions comprising thalidomide for the treatment and management of pulmonary hypertension
JP2008533022A5 (https=)
JP5805891B2 (ja) 5−ヒドロキシ−1h−イミダゾール−4−カルボキサミドを含有する錠剤
CN108743601A (zh) 一种抗溃疡性结肠炎的黄芩苷-黄芩素组合物及其制剂
CN103933195B (zh) 一种中药组合物及其在制备防治肝疾病药物中的应用
CN103893226A (zh) 肉豆蔻提取物的应用